Alkem launches indigenously-developed semaglutide in India with weekly dosing from ₹450, offering disposable and reusable pens to improve affordability and adherence.
AI Assistant
Alkem Laboratories Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.